Rekombinanter IL2RA (Daclizumab Biosimilar) Antikörper
-
- Target Alle IL2RA (Daclizumab Biosimilar) Produkte
- IL2RA (Daclizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human
-
Wirt
-
Human
- Expressionssystem
- CHO Cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL2RA (Daclizumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
- Verwendungszweck
- Anti-IL-2Ra / CD25 Reference Antibody (daclizumab)
- Sequenz
- QVQLVQSGAE VKKPGSSVKV SCKASGYTFT SYRMHWVRQA PGQGLEWIGY INPSTGYTEY NQKFKDKATI TADESTNTAY MELSSLRSED TAVYYCARGG GVFDYWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIQMTQSPST LSASVGDRVT ITCSASSSIS YMHWYQQKPG KAPKLLIYTT SNLASGVPAR FSGSGSGTEF TLTISSLQPD DFATYYCHQR STYPLTFGQG TKVEVKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
- Produktmerkmale
- Anti-IL-2Ra / CD25 Reference Antibody (daclizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- Reinheit
- >95 %
- Isotyp
- IgG1
-
anti-IL2RA (Daclizumab Biosimilar) antibody
Reaktivität: Human, Cynomolgus, Rhesusaffen FACS, BR Wirt: Kaninchen Chimeric unconjugated Recombinant Antibody
anti-IL2RA (Daclizumab Biosimilar) antibodyReaktivität: Human, Cynomolgus, Rhesusaffen FACS, BR Wirt: Human Monoclonal unconjugated Recombinant Antibody
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Therapeutic Agents by Target and Mechanism: IL-2Ra inhibitors
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- +4°C,-80°C
-
- Target
- IL2RA (Daclizumab Biosimilar)
- Andere Bezeichnung
- IL-2Ra (Daclizumab Biosimilar) (IL2RA (Daclizumab Biosimilar) Produkte)
- Substanzklasse
- Biosimilar
- Molekulargewicht
- 145.5 kDa
- UniProt
- P01589
-
